본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Range shift verification in spot scanning proton therapy using gamma electron vertex imaging Chan Hyeong Kim
Chan Hyeong Kim:김성훈:정종휘, 이세병, 신동호, 임영경, 김학수. Range shift verification in spot scanning proton therapy using gamma electron vertex imaging MEDICAL PHYSICS. 2023-09-18; 2023; :~. IF 3.8 (2022)
김성훈
(양성자치료센터)
Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021 최귀선
(암관리학과)
최귀선:Xuan Quy Luu:이경민, 전재관, 서민아. Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021 EPIDEMIOLOGY AND HEALTH. 2023-09-17; 2023; 45:e2023086~. IF 3.8 (2022)
Luu Xuan QUY
(암관리학과)
Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study 정소연
(암진료향상연구과)
정소연, Young-Joo Won:이은경3:임명철, 장윤정. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study FRONTIERS IN ONCOLOGY. 2023-09-14; 2023; 13:1208320~. IF 4.7 (2022)
이은경3
(외과)
Zinc intake, SLC30A8 rs3802177 polymorphism, and colorectal cancer risk in a Korean population: a case-control study 김정선
(암AI디지털헬스학과)
김정선:Linh Thi Dieu Nguyen:Madhawa Gunathilake, 이정희, 오재환, 장희진, 손대경. Zinc intake, SLC30A8 rs3802177 polymorphism, and colorectal cancer risk in a Korean population: a case-control study JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023-09-14; 2023; 149(18):16429~16440. IF 3.6 (2022)
Linh Thi Dieu NGUYEN
(암의생명과학과)
The effect of fragmented cancer care and change in nurse staffing grade on cancer patient mortality Seungju Kim
Seungju Kim:한규태:. The effect of fragmented cancer care and change in nurse staffing grade on cancer patient mortality WORLDVIEWS ON EVIDENCE-BASED NURSING. 2023-09-10; 2023; 20(6):610~620. IF 4.3 (2022)
한규태
(암관리정책부)
(Grant 수정 필요)Gastroesophageal Reflux Disease and Risk of Cancer: Findings from the Korean National Health Screening Cohort 오진경
(암관리학과)
오진경:Chi Lan Tran:김병미, 김영일, Minji Han, Eun Young Park. (Grant 수정 필요)Gastroesophageal Reflux Disease and Risk of Cancer: Findings from the Korean National Health Screening Cohort CANCER MEDICINE. 2023-09-07; 2023; 12(18):19163~19173. IF 4 (2022)
Chi Lan Tran
Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression 한지연1
(폐암센터)
한지연1:박찬이, 안병철:이상진, 홍세화, 권경숙, 김진영, 김경희, 김혜영, 이건국, 이영주, Ji-Eun Hwang. Nivolumab after Induction Chemotherapy in Previously Treated Non-Small-Cell Lung Cancer Patients with Low PD-L1 Expression CANCERS. 2023-09-07; 2023; 15(18):4460~. IF 5.2 (2022)
박찬이
(생물정보연구과)
안병철
(혈액종양내과분과)
Bidirectional connectivity alterations in schizophrenia: a multivariate, machine-learning approach Minchul Kim
Minchul Kim:서지원, Minhoe Kim:Seokho Yun. Bidirectional connectivity alterations in schizophrenia: a multivariate, machine-learning approach FRONTIERS IN PSYCHIATRY. 2023-09-07; 2023; 14:1232015~. IF 4.7 (2022)
서지원
(영상의학과)
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer 정소연
(외과)
이은경3
(외과)
정소연, 이은경:송란:이동은, 이시연, 강한성, 한재홍, 이근석, 심성훈, 채희정, 권영미, 우재연. Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast Cancer CANCERS. 2023-09-07; 2023; 15(18):4451~. IF 5.2 (2022)
송란
(외과)
Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey 임명철
(자궁난소암센터)
임명철:김지현:김시내, 서상수, 강석범, 박상윤, Yumi Lee, Da-Young Kim. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-09-05; 2023; 35(1):e3~. IF 3.9 (2022)
김지현
(산부인과)